Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Moxifloxacin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 336Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IPC Developing IP Reference Standards For Anti-Tb Drug
    IPC Developing IP Reference Standards For Anti-Tb Drug

    22 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183692&sid=1

    PHARMABIZ
    22 Jan 2026
    Share Share
    Enforcement Report - Week of January 14, 2026
    Enforcement Report - Week of January 14, 2026

    14 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-14-2026-32682.pdf

    FDA
    14 Jan 2026
    Share Share
    Lancet Regional Health Releases Key Phase 3 Study On Miqnaf
    Lancet Regional Health Releases Key Phase 3 Study On Miqnaf

    26 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/the-lancet-regional-health-publishes-pivotal-phase-3-clinical-study-on-miqnaf-17880

    INDPHARMAPOST
    26 Sep 2025
    Share Share
    Health Canada Issues Recalls of Sanis Health`s Moxifloxacin
    Health Canada Issues Recalls of Sanis Health`s Moxifloxacin

    02 Jun 2025

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/sanis-moxifloxacin-solution-sterility-issue

    HEALTH CANADA
    02 Jun 2025
    Share Share
    Enforcement Report - Week of June 19, 2024
    Enforcement Report - Week of June 19, 2024

    19 Jun 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2024-84054.pdf

    FDA
    19 Jun 2024
    Share Share
    Enforcement Report - Week of June 5, 2024
    Enforcement Report - Week of June 5, 2024

    05 Jun 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-5-2024-58484.pdf

    FDA
    05 Jun 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.